Thursday, July 23, 2009 5:05:10 PM
close Email this News Article
Your Name
Your Email
Friend's Name
Friend's Email
Receive Copy: yes
BIEL 0.054 0.002
Today 5d 1m 3m 1y 5y 10y
Skymark Research Initiates Complimentary Research Coverage On BioElectronics Corporation
Skymark Research Initiates Complimentary Research Coverage On BioElectronics Corporation
CALGARY, Alberta, July 23, 2009 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on BioElectronics Corporation (Pink Sheets:BIEL). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com
About SMR:
Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php
About BioElectronics Corp.(Pink Sheets:BIEL):
BioElectronics Corporation (Pink Sheets:BIEL) is the maker of ActiPatch(r) Therapy, RecoveryRx(tm) Devices, HealFast(tm) Therapy (www.healfasttherapy.com) and the Allay(tm) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.
SMR Disclosure:
Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.
CONTACT: Skymark Research
Dylan Boyle
202-657-6249
info@skymarkresearch.com
Source: GlobeNewswire (July 23, 2009 - 9:30 AM EDT)
ALSO---THAT 6 MILLION SHARE TRADE CO8ULD BE A CATCH-UP PRINT FROM AN EARLIER TRADE--
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM